指南与共识心力衰竭与心肌病

晚期心力衰竭中肾功能障碍的评估与管理:美国心脏协会科学声明

Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association.
指南 / 共识 · Circulation · 2024-09-10

该科学声明聚焦晚期心力衰竭患者肾功能障碍的临床管理,强调早期识别肾功能障碍对及时干预至关重要,并提出肾功能障碍不仅包括血肌酐升高,还涵盖钠和容量稳态维持不足、尿毒症溶质潴留及内分泌功能紊乱。声明围绕晚期心衰临床轨迹中肾功能评估的概念框架、晚期外科治疗(持久左心室辅助装置/心脏移植)及肾脏替代治疗的围术期评估管理、以及姑息治疗与决策制定的关键概念展开。

要点

  • 早期识别晚期心衰患者的肾功能障碍对及时干预至关重要。
  • 肾功能障碍涵盖血肌酐升高、钠和容量稳态维持不足、尿毒症溶质潴留及内分泌功能紊乱。
  • 量化潜在不可逆性肾实质疾病程度对预测优化淤血和指南导向药物治疗能否稳定肾功能至关重要。

核心结论

  • 早期识别晚期心衰患者的肾功能障碍对及时干预至关重要。
  • 量化潜在不可逆性肾实质疾病程度有助于预测优化淤血和指南导向药物治疗能否稳定肾功能。

研究设计与样本

  • 美国心脏协会(AHA)科学声明。

主要发现

  • 肾功能障碍除血肌酐升高外,还包括钠和容量稳态维持不足、尿毒症溶质潴留及内分泌功能紊乱。
  • 血流动力学紊乱和适应不良的神经激素上调可导致肾脏指标和电解质波动,这些波动可能随指南导向药物治疗而恢复。

临床怎么用

  • 在晚期心衰临床轨迹中评估肾功能障碍,包括考虑晚期心衰治疗时。
  • 针对晚期外科治疗(持久左心室辅助装置/心脏移植)和肾脏替代治疗,采用术前、围术期和术后的肾脏疾病评估与管理方法。
  • 关注合并晚期心衰和肾脏疾病个体特有的姑息治疗和决策制定过程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. In addition to elevations in serum creatinine, kidney dysfunction encompasses inadequate maintenance of sodium and volume homeostasis, retention of uremic solutes, and disrupted endocrine functions. Hemodynamic derangements and maladaptive neurohormonal upregulations contribute to fluctuations in kidney indices and electrolytes that may recover with guideline-directed medical therapy. Quantifying the extent of underlying irreversible intrinsic kidney disease is crucial in predicting whether optimization of congestion and guideline-directed medical therapy can stabilize kidney function. This scientific statement focuses on clinical management of patients experiencing kidney dysfunction through the trajectory of advanced heart failure, with specific focus on (1) the conceptual framework for appropriate evaluation of kidney dysfunction within the context of clinical trajectories in advanced heart failure, including in the consideration of advanced heart failure therapies; (2) preoperative, perioperative, and postoperative approaches to evaluation and management of kidney disease for advanced surgical therapies (durable left ventricular assist device/heart transplantation) and kidney replacement therapies; and (3) the key concepts in palliative care and decision-making processes unique to individuals with concomitant advanced heart failure and kidney disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Tang, Bakitas, Cheng, et al. Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2024. PMID: 39253806. doi:10.1161/CIR.0000000000001273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。